Sources of information used on our site. 1 Murphy B.G., et al (2018). The nucleoside analog GS-441524 strongly inhibits FIP virus in tissue culture and experimental cat infection studies. Vet Microbiol 219; 255-233.2 Zuzzi-Krebitz, A. M., et al (2024). Short Treatment of 42 Days with Oral GS-441524 Results in Equal Efficacy as the Recommended 84-Day Treatment in Cats Suffering from Feline Infectious Peritonitis with Effusion-A Prospective Randomized Controlled Study. Viruses, 16(7), 1144.3 Pedersen N.C., et al (2019). Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis. JFMS, 21(4):271-281.4 Duthie, S., et al (1997). Value of alpha 1-acid glycoprotein in the diagnosis of feline infectious peritonitis. The Veterinary record, 141(12), 299–303. 5 Hazuchova, K., Held, S., & Neiger, R. (2017). Usefulness of acute phase proteins in differentiating between feline infectious peritonitis and other diseases in cats with body cavity effusions. Journal of feline medicine and surgery, 19(8), 809–816. 6 Addie, D. D., et al (2022). Alpha-1 Acid Glycoprotein Reduction Differentiated Recovery from Remission in a Small Cohort of Cats Treated for Feline Infectious Peritonitis. Viruses, 14(4), 744. 7 Helfer-Hungerbuehler., et al (2024). Alpha-1-Acid Glycoprotein Quantification via Spatial Proximity Analyte Reagent Capture Luminescence Assay: Application as Diagnostic and Prognostic Marker in Serum and Effusions of Cats with Feline Infectious Peritonitis Undergoing GS-441524 Therapy. Viruses, 16(5), 791. This article was published on 2024-12-13
